Sanofi India Limited — Updates, 04-08-2026: General Updates
04-08-2026 | 08:29 pm
04-08-2026 | 08:29 pm
Sanofi India reported strong Q2 results: Net sales rose 6% and PBT before exceptional items increased 19% to ₹112.3 Cr, driven by 14% diabetes portfolio growth. The Board reconstituted committees, and the CFO will step down effective Sept 30.
No comments yet. Be the first to comment!
